期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
基于IRAK4/ERK/p38信号通路雷公藤红素对多发性骨髓瘤细胞增殖和凋亡的影响 被引量:5
1
作者 徐小梦 康迪 +5 位作者 朱新宇 孔祥图 于慧 陈晓丽 姜鹏君 倪海雯 《中国实验血液学杂志》 CAS CSCD 北大核心 2022年第1期175-182,共8页
目的:探讨雷公藤红素对人多发性骨髓瘤细胞增殖和凋亡的影响,并揭示IRAK4/ERK/p38信号通路与雷公藤红素调控H929、ARP-1细胞增殖和凋亡的关系,探究雷公藤红素联合硼替佐米是否具有协同作用。方法:采用CCK-8法检测多发性骨髓瘤细胞株H929... 目的:探讨雷公藤红素对人多发性骨髓瘤细胞增殖和凋亡的影响,并揭示IRAK4/ERK/p38信号通路与雷公藤红素调控H929、ARP-1细胞增殖和凋亡的关系,探究雷公藤红素联合硼替佐米是否具有协同作用。方法:采用CCK-8法检测多发性骨髓瘤细胞株H929、ARP-1细胞经不同浓度雷公藤红素、硼替佐米以及二者联用后的细胞活力,并利用金氏公式判定协同药效。Annexin V/PI法检测H929细胞凋亡率和ARP-1细胞坏死率。蛋白免疫印迹法检测雷公藤红素对IRAK4/ERK/p38信号通路中关键蛋白和凋亡蛋白表达的影响。结果:雷公藤红素能够呈时间-浓度依赖性地显著抑制H929、ARP-1细胞的增殖(r=0.9018,0.9244),并诱导细胞的凋亡;与对照组比较,雷公藤红素能够明显上调H929、ARP-1细胞内PARP、cleaved caspase-3表达,下调p-IRAK4、p-ERK、p-p38表达。雷公藤红素、硼替佐米单用对H929、ARP-1细胞均有增殖抑制作用,而联合用药与单药相比,前者细胞存活率更低,凋亡率更高(P<0.05)。结论:雷公藤红素能抑制H929和ARP-1细胞增殖、促进其凋亡,其机制可能与抑制IRAK4的磷酸化、阻断IRAK4/ERK/p38信号通路的激活有关;雷公藤红素联合硼替佐米具有协同作用,能更有效地抑制H929、ARP-1细胞增殖并诱导其凋亡。 展开更多
关键词 雷公藤红素 多发性骨髓瘤 硼替佐米 H929 ARp-1 irak4/erk/p38信号通路
下载PDF
MAPK/ERK regulation of P53 in human epidermoid carcinoma cell line A431
2
作者 Yuqin Hao Chunyi Kang +2 位作者 Xin Zhang Shuxia Kang Xia Liu 《Discussion of Clinical Cases》 2018年第4期23-29,共7页
Objective:To observe the impact of activation and inhibition of mitogen activated protein kinases(MAPK)/extracellular signalregulated protein kinase(ERK)signaling pathway on the proliferation and apoptosis of cutaneou... Objective:To observe the impact of activation and inhibition of mitogen activated protein kinases(MAPK)/extracellular signalregulated protein kinase(ERK)signaling pathway on the proliferation and apoptosis of cutaneous squamous cell carcinoma(SCC).cells and investigate the interaction mechanism between MAPK/ERK signaling pathway and tumor suppressor gene P53 in SCC.Methods:Human A431 cells were cultured and divided into MAPK/ERK inhibition groups with low-,medium-and highconcentration of inhibitors(PD98059+DMSO),MAPK/ERK activation groups with low-,medium-and high-concentration of stimuli(IGF+PBS)and blank control group(DMSO).The cell proliferation in vitro was detected by MTT assay,with the cell apoptosis detected by flow cytometry(FCM)and the protein expression of P-ERK and P53 detected by western blot in each group.Results:The A431 cell proliferation was inhibited by different concentrations of PD98059 with a clear concentration-effect and time-effect relationship(p<.05);and the cell proliferation was promoted by the different concentrations of IGF with a clear concentration-effect and time-effect relationship(p<.05).The FCM results showed a significant increase in the apoptosis rate of A431 cells which were treated with PD98059,with a clear concentration-effect relationship(p<.05);while the apoptosis rate was decreased significantly after A431 cells were treated with IGF,also with a concentration-effect relationship(p<.05).The western blot results showed that the expression of P-ERK protein was decreased but the expression of P53 was increased after A431 cells were treated with PD98059.With the concentration of PD98059 going up,the decrease in P-ERK and the increase in P53 were more significant(p<.05);while the expression of P-ERK protein was increased but the expression of P53 was decreased after A431 cells were treated with IGF.With the concentration of IGF going up,the increase in P-ERK and the decrease in P53 were more significant(p<.05).According to Pearson correlation analysis,the expression of P53 was negatively correlated to that of P-ERK(p<.05).Conclusions:After MAPK/ERK signaling pathway was activated by IGF in A431 cells,the expression of pro-apoptotic factor P53 was decreased with the ability of cell proliferation enhanced and the ability of apoptosis reduced.However,after the inhibition of MAPK/ERK signaling pathway,the expression of pro-apoptotic factor P53 was increased with the ability of cell proliferation reduced and the ability of apoptosis increased. 展开更多
关键词 Cutaneous squamous cell carcinoma MApK/erk signaling pathway p53
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部